Vijaya Gadde
Known title: DirectorCIK: 0001590851
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Guardant Health Wins Patent Ruling, Morgan Stanley Lifts Target. Guardant Health secured a favorable decision from the U.S. Patent Trial and Appeal Board, which rejected a challenge to its core duplex sequencing patent. This legal win supports the company's position in the growing liquid biopsy market. Additionally, Morgan Stanley maintained an Overweight rating and raised its price target to $200, citing strong fundamentals in the diagnostics sector.
Transaction History
| PL | ▲ Buy | Grant | 6,479 | $0 | 7/9/2026 | View on chart |
| GH | ▲ Buy | Option Exercise | 4,203 | $0 | 6/17/2026 | View on chart |
| PL | ▼ Sell | Open Market | 20,000 | $535K | 1/22/2026 | View on chart |
| PL | ▲ Buy | Grant | 32,468 | $0 | 7/10/2025 | View on chart |
| GH | ▲ Buy | Option Exercise | 6,674 | $0 | 6/12/2025 | View on chart |
| PL | ▲ Buy | Grant | 93,583 | $0 | 7/11/2024 | View on chart |
| GH | ▲ Buy | Option Exercise | 5,592 | $0 | 6/12/2024 | View on chart |
| PL | ▲ Buy | Grant | 54,055 | $0 | 7/11/2023 | View on chart |
| PL | ▲ Buy | Grant | 40,541 | $0 | 7/11/2023 | View on chart |
| GH | ▲ Buy | Option Exercise | 5,531 | $0 | 6/14/2023 | View on chart |
| PL | ▲ Buy | Grant | 37,808 | $0 | 11/9/2022 | View on chart |
| PL | ▲ Buy | Grant | 11,714 | $0 | 9/8/2022 | View on chart |
| GH | ▲ Buy | Option Exercise | 1,814 | $0 | 6/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Planet Labs (PL) launches 20 satellites amid stock decline
Planet Labs placed a new batch of 20 satellites into orbit this week, expanding its global imaging coverage. The launch follows several recent articles noting a sharp drop in the stock price, with declines of more than 50% over the past six months and a recent surge after the launch. The company also appeared on Fortune’s Future 120 list for 2026, highlighting its growth potential. Analysts have an average target price of $33.40, while the share trades near the $15.99 support level.
Planet Labs (PL) launches 20 satellites amid stock decline. Planet Labs placed a new batch of 20 satellites into orbit this week, expanding its global imaging coverage. The launch follows several recent articles noting a sharp drop in the stock price, with declines of more than 50% over the past six months and a recent surge after the launch. The company also appeared on Fortune’s Future 120 list for 2026, highlighting its growth potential. Analysts have an average target price of $33.40, while the share trades near the $15.99 support level.